SYN-Tech Chem & Pharm Co Ltd (1777) - Cash Flow Conversion Efficiency
Based on the latest financial reports, SYN-Tech Chem & Pharm Co Ltd (1777) has a cash flow conversion efficiency ratio of 0.099x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$256.05 Million ≈ $8.07 Million USD) by net assets (NT$2.59 Billion ≈ $81.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is SYN-Tech Chem & Pharm Co Ltd's balance sheet to measure how much of total assets are equity-financed.
SYN-Tech Chem & Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how SYN-Tech Chem & Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 1777 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
SYN-Tech Chem & Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of SYN-Tech Chem & Pharm Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sagittarius Life Science
TWO:3205
|
-0.020x |
|
Konya Kagit Sanayi ve Ticaret AS
IS:KONKA
|
-0.023x |
|
Nicola Mining Inc
V:NIM
|
0.542x |
|
Alpha Astika Akinita S.A
AT:ASTAK
|
-0.330x |
|
Marks and Spencer Group PLC
LSE:MKS
|
0.289x |
|
Synergy Green Industries Limited
NSE:SGIL
|
0.056x |
|
Suraj Estate Developers Ltd.
NSE:SURAJEST
|
0.008x |
|
Fabryki Mebli Forte S.A.
WAR:FTE
|
0.023x |
Annual Cash Flow Conversion Efficiency for SYN-Tech Chem & Pharm Co Ltd (2015–2025)
The table below shows the annual cash flow conversion efficiency of SYN-Tech Chem & Pharm Co Ltd from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see how much is SYN-Tech Chem & Pharm Co Ltd worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$2.59 Billion ≈ $81.61 Million |
NT$559.49 Million ≈ $17.63 Million |
0.216x | -11.18% |
| 2024-12-31 | NT$2.56 Billion ≈ $80.66 Million |
NT$622.61 Million ≈ $19.62 Million |
0.243x | +114.86% |
| 2023-12-31 | NT$2.32 Billion ≈ $73.01 Million |
NT$262.29 Million ≈ $8.26 Million |
0.113x | -43.27% |
| 2022-12-31 | NT$2.20 Billion ≈ $69.29 Million |
NT$438.81 Million ≈ $13.83 Million |
0.200x | +152.09% |
| 2021-12-31 | NT$1.98 Billion ≈ $62.49 Million |
NT$156.98 Million ≈ $4.95 Million |
0.079x | -69.24% |
| 2020-12-31 | NT$1.24 Billion ≈ $39.08 Million |
NT$319.21 Million ≈ $10.06 Million |
0.257x | +30.86% |
| 2019-12-31 | NT$1.16 Billion ≈ $36.55 Million |
NT$228.12 Million ≈ $7.19 Million |
0.197x | +14.63% |
| 2018-12-31 | NT$1.10 Billion ≈ $34.62 Million |
NT$188.49 Million ≈ $5.94 Million |
0.172x | +298.39% |
| 2017-12-31 | NT$996.24 Million ≈ $31.39 Million |
NT$42.89 Million ≈ $1.35 Million |
0.043x | -81.19% |
| 2016-12-31 | NT$1.03 Billion ≈ $32.37 Million |
NT$235.26 Million ≈ $7.41 Million |
0.229x | +48.07% |
| 2015-12-31 | NT$969.06 Million ≈ $30.53 Million |
NT$149.84 Million ≈ $4.72 Million |
0.155x | -- |
About SYN-Tech Chem & Pharm Co Ltd
SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers test drugs and surfactants, as well as various Chinese, Western, and animal medicines. It also provides products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relax… Read more